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Laparoscopy Shows a Benefit in a
Growing Number of Oncologic Procedures
by Sunni Hosemann

n little more than a decade,
laparoscopic procedures
have revolutionized sur~
gery, replacing many types
of conventional open procedures.
Today, laparoscopic surgery is
a standard choice for most gall~
bladder removals and has become
an acceptable alternative to
many other open procedures:
hemiorrhaphy, appendectomy,
splenectomy, gastric bypass,
and a number of gynecologic
procedures. In many cases, it
can be offered in place of an
open laparotomy for exploratory
purposes. But the trend toward
laparoscopic surgery in malignan~
cies has been slower-and more
controversial.

I

The main advantage of laparoscopic
surgery over an open procedure is that it
(Continued on next page)

Viewing the procedure through a laparoscope, Dr. Barry Feig , an associate professor
in the Department of Surgical Oncology, performs a jejunostomy on a patient with gastric
cancer. The use of laparoscopy in oncologic surgery is expanding.
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requires smaller incisions, which trans,
lates into less pain, less pain medication,
and earlier ambulation-in short, a
quicker recovery. In some cases, the
difference can be dramatic: for example,
a conventional adrenalectomy requires a
very large incision that traverses the
entire abdomen diagonally to provide
the surgeon with adequate visualization
of the adrenal glands. This operation
typically results in an extended hospital
stay and may also require a blood
transfusion. By contrast, laparoscopic
adrenalectomy is a much less invasive
operation that leaves the patient with
only small puncture wounds.

Laparoscopy in oncologic surgery
Cancer surgery, however, poses
some unique challenges that make
the application of laparoscopic surgery
in oncology more problematic. First,
because the relationship of a tumor to
the tissues that surround it is critically
important in cancer staging, specimens
or whole organs should be removed
intact (en bloc) so that pathologists
can properly examine them and measure
and document the depths and margins
of tumor invasion. A second concern
for surgical oncologists is cell transfer or
cell spillage: diseased tissue must be
removed without contaminating
adjacent tissues and structures with
cancer cells. Because of these concerns,
tissue morcellation-a technique
commonly used in noncancer laparo,
scopic surgery in which the tissue is
divided into Qieces so that it can be
removed more easily-should not
be used for oncologic procedures.
One of the early concerns about
laparoscopic procedures in oncology
was that they caused so,called porHite
recurrences or trocar metastases-the
appearance of recurrent tumor tissue at
the site of trocar entry. In a five,year
study of all laparoscopic procedures at
The University of Texas M. D. Anderson
Cancer Center (performed in more than
500 patients), there were four porHite
recurrences, and three of these patients
had widespread tumor growth elsewhere.
This result is not different from those
seen in studies of open,procedure
2
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incisions, according to Barry Feig, M.D.,
an associate professor in the Department
of Surgical Oncology at M. D. Anderson,
who said that this type of recurrence is
now generally considered to be related
to biologically aggressive disease rather
than to the type of incision.
New techniques for removing tissue
have helped increase the number and
types of oncologic surgeries that can be
done laparoscopically. In some cases, the
tissue to be removed is first encased in
a specimen retrieval bag. And for many
procedures, a hand,assisted technique
is used, wherein the surgeon uses his or
her hand, inserted through the initial
incision, to aid in the exploration,
isolation, and removal of tissue. This
hand,assisted technique offers distinct
advantages-the superior visualization
afforded by the laparoscope and a tactile
component that is important in many
aspects of surgery-and has allowed
surgeons to apply a less invasive ap,
proach to surgeries that previously could
not have been done laparoscopically.
Hand,assisted laparoscopy can also serve
as a bridge between open surgery and
straight laparoscopy, making it easier for
surgeons to practice and learn the skills
necessary for performing laparoscopic
procedures.

Laparoscopic prostatectomy
These kinds of refinements and
knowledge developed through research
have contributed to the expanding use
of laparoscopy in some of the areas of
oncology where its application was
previously in question. "In certain
urologic oncology procedures, such
as nephrectomy, laparoscopic surgery
may soon be a standard of care," said
Christopher Wood, M.D., an assistant
professor in the Department of Urology.
Dr. Wood was not himself an early
enthusiast of laparoscopic surgery,
but he has come to see its benefits for
patients. He recalled that in the final
days of his residency at Northwestern
University Medical School in Chicago,
he was dispatched to the airport to pick
up a nationally renowned expert who
had come to demonstrate laparoscopic
radical prostatectomy, then a novel

procedure. "That operation took 12
hours," Dr. Wood recalled, "but over the
years, it h as become refined to the point
that it is more routine." Nonetheless,
he points out that even today, most
prostatectomies are not done laparo,
scopically because of the very steep
learning curve associated with laparo,
scopic prostatectomy and because the
morbidity rate of conventional prosta,
tectomy compares very favorably with
that of the laparoscopic technique.
Laparoscopic prostatectomy does
have benefits, however. Surgeons say
that, for anatomical reasons, visualiza,
tion of the prostate is much better
laparoscopically than in an open
procedure. A ccording to Surena Matin,
M.D., an assistant professor in the
Department of Urology, there are
advantages to radical prostatectomy
done laparoscopically: for example, less
bleeding, more precise suturing of the
bladder to the urethra, and five small
puncture wounds versus one long
(eight, to nine,inch) incision.
"We also know that return of bladder
control is as good or better than it is
after conventional surgery. And although
we do not yet h ave good information
about the return of erectile function,
the reported outcomes we do have
suggest equivalency when a nerve,
sparing procedure is done," Dr. Matin
said. "Additionally, there are no long,
term data yet about cancer control.
Outcomes based on specimens from
both kinds of procedures appear to be
equivalent, as do data from a recent
three,year follow,up study."

Kidney cancer surgery
Perhaps the biggest impact of
laparoscopic surgery in urologic oncol,
ogy has been seen in cancers of the
kidney. The first laparoscopic radical
nephrectomy was performed in 1990,
and for several years after that its value
was questioned because of its complex,
ity. "Today, after thousands have been
performed, laparoscopic approaches to
kidney cancer surgery, including hand,
assisted laparoscopy, are rapidly becom,
ing the standard of care in most major
centers," said Dr. Wood. Many patients

A related procedure that is even less
invasive is percutaneous radiofrequency
ablation conducted under computed
tomographic (CT) guidance. This
technique, done with the help of an
interventional radiologist, is currently
under investigation. "We have no longterm data for it yet," said Dr. Matin,
"but it highlights the fact that patients
with small tumors have tremendous
options now, whereas 10 years ago, they
would require removal of a whole or
partial kidney with a large incision."

In the top photo, Dr. Surena Matin (right), an assistant professor in the Department of Urology, and Dr. Carlos Bermejo, a fellow in the Department of Urologic
Oncology (TIC), perform a laparoscopic nephrectomy on a patient with kidney cancer.
The bottom photo shows the resected kidney with tumor (above a 15 -cm ruler) and the
small incision in the patient's abdomen.
who are treated at M. D. Anderson for
kidney cancer undergo surgery using
a laparoscopic technique.
"We believe that there is less
morbidity, there is less bleeding, less
pain, a faster recuperation, and also a
cosmetic advantage. And the results
of two five-year, case-control follow-up
studies indicate that it is comparable
to open removal in terms of cancer
outcomes," said Dr. Matin. Although
the open procedure is still considered
the gold standard for partial nephrectomy, the use of laparoscopy is increas-

ing in cases where the tumors are small,
particularly if they are on the surface of
the kidney.
Another advance in the treatment
of small renal tumors is the use of
laparoscopic cryoablation. This procedure is associated with remarkably little
morbidity and so can be offered to
patients who are not able to undergo a
more extensive procedure. "Although
the curative effects of this technique are
not yet known, three-year follow-up
indicates good results, as long as patients
are carefully selected," said Dr. Matin.

A staging tool
According to Paul Mansfield, M.D.,
a professor in the Department of
Surgical Oncology at M. D. Anderson,
laparoscopy has found one of its most
useful roles in oncology as a staging tool,
and nowhere is its benefit greater than
in gastric cancer. Laparoscopy and
endoscopic ultrasonography can help
identify patients who could be cured
by a gastric resection, those who could
benefit from preoperative systemic
chemotherapy, and those who would
not benefit (and can thus be spared)
from this major operation.
Dr. Mansfield and Dr. Feig, along
with their colleagues at M. D. Anderson, have described a laparoscopic
technique that uses water to improve
the visualization of peritoneal surfaces
in gastric, pancreatic, and other intraabdominal solid-organ malignancies.
Using this technique, investigators are
able to visualize metastases so small
that they cannot be detected by highcontrast CT. As many as 25% of
patients with gastric cancers are found
to have CT-occult metastases; laparotomy would not be therapeutic for these
patients, and so they can be spared the
morbidity of a large operation.
At M. D. Anderson, patients with
gastric cancer routinely undergo this
type of laparoscopic staging unless
an urgent gastrectomy is necessary to
control bleeding or remove an obstruction. Typically during the staging
laparoscopy, fluid is also injected into
the abdomen to obtain cytologic wash
specimens, a valuable contribution to
(Continued on page 4)
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(Continued from page 3)

the staging picture that can help further
refine care and identify suitable protocols for individual patients. It is also
common during this procedure to place
a feeding tube, which provides supportive nutrition to the patient during the
course of treatment. More than half of
patients with gastric cancer have lost
10% of their total body weight or more
by the time their disease is discovered,
and this can set the stage for complications from the disease or its treatment.

The learning curve
In much of the literature on
laparoscopic surgery, the learning curve
for performing the technique is described
as steep. In fact, laparoscopy is more
than a new technique; it is a completely
different way of operating. The visualization is different, the instruments are
different, and the tactile aspects are very
different. lntracorporeal suturing, for
example, is a skill that requires a great
deal of practice: "As a young surgeon in
training, you sit up all night, night after
night, tying knots-over and over and
over again-until it becomes second
nature," said Or. Matin. "Then you do
the same thing all over again when you
learn to do it laparoscopically." And,
because laparoscopic surgery is relatively
new in practice, it has not been easy
for many surgeons to perform the number
of procedures (at least 50 in a given
technique) that experts say is necessary
to become adept. In addition, some
advanced laparoscopic procedures, such
as colon resection, require a team of
two surgeons, said Dr. Feig.
Not for everyone
Even in cases where the surgeon is
adequately trained and experienced,
however, a laparoscopic procedure
may not be the best approach. For
some surgeries, both oncologic and
nononcologic, laparoscopy has an
established benefit: quicker recovery
time with similar disease control. For
others, such a benefit has not been
proven. An example still requiring study
is laparoscopic colon resection for colon
cancer. One might assume that the
short-term quality of life would be
4
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"As a young surgeon
in training, you sit up
all night, night after
night, tying knotsover and over and over
again-until it becomes
second nature. Then
you do the same thing
all over again when
you learn to do it
laparoscopically."
- Surena Matin, M.D., assistant
professor, Department of Urology

better for patients who undergo
laparoscopic surgery and that the real
question would be whether the longterm survival rates for laparoscopic
colectomy are comparable to those for
standard colectomy. But according to
Dr. Feig, two recent studies conducted
elsewhere have presented surprising
results: in one, no difference in quality
of life was seen, and in the other, higher
five-year survival rates were reported for
the laparoscopic procedure. These
results are the opposite of what one
might expect, so more study is obviously
needed.
"This raised the question of whether
quality of life actually is enhanced [by
laparoscopic colectomy]," said Dr. Feig.
"For a colectomy, the hospital stay after
the laparoscopic procedure is not very
much different (six versus seven days),
but we think that people return to their
normal activities sooner. It's a difficult
thing to measure, however, and one
wonders how much it has to do with
the patient population being studied."
Although it is performed in select
patients who can benefit from it,
laparoscopic colectomy for colon
cancer is not routinely offered as a
primary treatment at M. 0. Anderson
because colon cancer resections often
include removal of the lymph nodes

for lymphatic mapping, which is under
investigation in colon cancer. "And
it's important to figure out that question
first," Or. Feig said. "Our primary
concern, as always, is treating the
cancer fu lly."
A given surgical procedure is heavily
influenced by the disease or condition
th at necessitates it, and the changes
wrought in an organ by cancer can be
a factor in choosing a method of
resection. Splenectomies, for example,
are performed somewhat routinely by
laparoscopy in noncancerous conditions
such as idiopathic thrombocytopenic
purpura, but this approach is not always
an option for cancer surgery. The spleen
is normally a small organ, "but the ones
we tend to see," said Dr. Feig, "can be
very large-four to five times normal
size-and boggy [blood engorged] and
thus very difficult to remove with
instruments. In many cases, it can be
removed more quickly and safely by
open procedure."
Patient characteristics also play a
role. For example, laparoscopic colon
resection is generally less suitable for
patients who are large or obese, and
conversion to an open procedure is
required more often in such patients
because tissue thickness impairs the
identification of important structures
and because manipulating the tissue can
be laborious, increasing operative time.

The bottom line
According to Dr. Feig, though
laparoscopic surgery is controversial in
oncology, "this is not an issue that
requires us to be either enthusiast or
nihilist. " There are clearly situations
where there is a demonstrable benefit
from laparoscopy, and the real question,
he said, is which patients will experience this benefit. "Our task is to identify
those patients," said Dr. Feig, "and
refine our techniques so that we can
offer it when it is most beneficial and
appropriate." •
FOR MORE INFORMATION, contact Dr. Feig
at (713) 794-1002 , Dr. Wood at (713)
792-3250, Dr. Matin at (713) 792-3250,
or Dr. Mansfield at (713) 794-5499 .

Collaboration and Creativity Lead
to a New Approach to Spinal Surgery
by Don Norwood

he word creativity
brings to mind
thoughts of fine
paintings or improvi-sational jazz, but a group of
physicians at The University of
Texas M. D. Anderson Cancer
Center recently expressed their
creative impulses through a more
unusual medium: spinal surgery.

T

Historically, when surgeons inserted
a plate to stabilize or reconstruct the
upper thoracic spine after performing a
vertebrectomy to remove a tumor, they
had to do so from the patient's back or
from an awkward angle in the front to
prevent injury to the aorta or superior
vena cava. The main problem with
these approaches was that they made it
difficult to place the screws needed to
secure the stabilizing plates on to the
upper thoracic spine.
"Because of the anatomic constraints
in the upper chest related to the over,
lying heart and major blood vessels,
trachea, esophagus, and nerves, getting
these plates secured to the spine can be

To optimally insert a thoracic spine stabilization plate after a vertebrectomy without harming
cardiovascular structures, Dr. Laurence Rhines (left), an assistant professor in the
Department of Neurosurgery and director of the Spine Program at M. D. Anderson, and
Dr. Garrett Walsh , a professor in the Department of Thoracic and Cardiovascular
Surgery, developed a technique called the interaortocaval subinnominate window (ISW).
very difficult, especially in terms of
getting the screws oriented in the proper
direction," said Laurence Rhines, M.D.,
an assistant professor in the Department
of Neurosurgery and director of the
Spine Program at M. D. Anderson.
Rather than continuing to labor under
these traditional methods, Dr. Rhines
sought out the help of a colleague to come

up with a new angle. "Dr. Garrett Walsh
[M.D., a professor in the Department of
Thoracic and Cardiovascular Surgery] was
our main collaborator with this project,"
Dr. Rhines said. "We had a case where
we could not position our screwdriver
at the optimal trajectory. With the
traditional approach, you can only push
(Continued on page 6)
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An artist's rendering shows the application of T3 screws via the interaortocaval subinnominate window (center) . A 40,French chest tube
is used as a sleeve to prevent the drill and screwdriver from entraining any of the surrounding tissues. Inset A shows an unsatisfactory
drilling trajectory at T3 with caudal retraction of the left innominate vein when a suprainnominate approach is used . In inset B, the
correct trajectory for drilling of the T3 screws is achieved using the interaortocaval subinnominate window. (Artist: Ian Suk)
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A New Approach to Spinal Surgery
(Continued from page 5)

the blood vessels down so far. We must
have mentioned this to Garrett one day
in the operating room."
Dr. Walsh responded by developing
an approach whereby he dissected
between the aorta and vena cava,
creating a surgical window through
which the neurosurgeons were able to
safely and optimally orient the screws.
Ors. Walsh and Rhines have termed
this technique the interaortocaval
subinnominate window (ISW).
"This was an example of a technique
that we developed together based on
their need to get to the spine and our
knowledge of how to move major
cardiovascular structures in the chest
away from the spine to allow them to
have optimal access fo r all of their
instrumentation," Dr. Walsh said.
To provide the needed access to the
thoracic spine in the ISW approach,

Dr. Walsh modified a method that had
been used for some time in combined
heart and double-lung transplantation.
Specifically, the pericardial sac containing the heart is open ed, the aorta i
mobilized and rotated to the patient's
left, the superior ven a cava i retracted
to the patient's right, and the trachea
and esophagus are moved away from
the spine as a unit.
"It's an approach that i part of our
cardiovascular armamentarium, but
recognizing its application to urgeon
in another discipline who are inter ted
in getting to another structure within
the thoracic cavity will occur when you
have the close collaboration that we
have within our Div ision of Surgery,"
Dr. Walsh said.
Surgeons in the department of
N eurosurgery and Thoracic and Cardiovascular Surgery have collaborated on
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FOR MORE INFORMATION , contact Dr.
Rhines at (7 13) 792-2400 or Dr. Walsh
at(713) 792-6849.

PROTOCOLS

Studies Test New Surgical Procedures
Clinical trials in progress at The University of Texas M. D. Anderson Cancer Center
include the following investigations of novel
surgical techniques and procedures.

•

•

•

6

Treatment of patients with stage 1B2
carcinoma of the cervix: a randomized
comparison of radical hysterectomy
and tailored chemoradiation versus
chemoradiation alone (GOG-0201 ).
Physician: Charles F Levenback, M. D.

•

uterine sarcoma (GOG LAP2). Physi-

trial (NS97-199) .

cian: Pedro Ramirez, MD.

Lang, MD.

A randomized trial evaluating the use of
fibrin tissue adhesive following axillary
node dissection in patients with breast
cancer (GS01-562). Physician: Barry

Feig, MD.
A randomized, phase II trial evaluating
• the
importance of early erectile dys-

A trial of lymphatic mapping and
sentinel node lymphadenectomy for
patients with T1 or T2 clinically NO
oral cavity squamous cell carcinoma
(ACOSOG 20360) . Physician: Jeffrey

function rehabilitation and unilateral
autologous sural nerve grafting in
patients undergoing a unilateral
cavernous nerve-sparing radical
prostatectomy for clinically local
prostate cancer (1001-304) . Physician:

Myers, MD. , Ph.D.

Christopher G. Wood, MD.

A phase Ill, randomized clinical trial
of laparoscopic pelvic and para-aortic
node sampling with vaginal hysterectomy and bilateral salpingo-oophorectomy versus open laparotomy with
pelvic and para-aortic node sampling
and abdominal hysterectomy and
bilateral salpingo-oophorectomy in
endometrial adenocarcinoma and
OncoLog • N ovember 2003

•

•

A randomized study of axillary lymph
node dissection in patients with clinical
T1 or T2 , NO, MO breast cancer who
have a positive sentinel node (1099336). Physician: Kelly K. Hunt, MD.

•

Surgery versus stereotactic radiosurgery in the treatment of single brain
metastases: a randomized prospective

•

Physician: Frederick

A phase Ill clin ical trial of Tiseel VH
fibrin sealant to reduce lymphedema
incidence after inguinal lymph node
dissection performed in the management of vulvar malignancies (GOG195). Physician: Pedro Ramirez, M.D.

A pilot study of laparoscopic extraperitoneal lymph node dissection in
patients with locally advanced cervical
cancer (1003-0098). Physician: Pedro

Ramirez, MD. •
FoR MORE INFORMATION about these
clinical trials, ph icians or patients ma
call the M . D. Anderson Infomiation Line.
Those within the United tate should call
(800) 392-1 611; those in Houston or
outside the United State should call ( 71 3)
792-3245. Visit the M. D . Anderson
Cancer Center clinical trials Web site at
http: //www.clinicaltrials.org for a broader
listing of treatment research protocols.

1

PHYSICIANS : THIS PATIENT INFORMATION SHEET

IS

YOURS TO COPY AND

PASS ON TO

PATIENTS .

Telling Fact from
Fiction on the Internet
he Internet can be a great resource for health informa-tion. A recent survey by the Pew Research Center found
that 81 % of Internet users expect to be able to find
reliable information about health or medical conditions
online. Unfortunately, the Internet is also an abundant source
of misinformation , and much of it is circulated year after year
through e--mail. The follo wing are some myths about cancer
that are currently circulating on the Internet.
INTERNET MYTH

#1

Wearing a bra causes
breast cancer.

oQfj:

Some ve~sions of the rumor specify
underwire bras. But underwire or not,
there is no validity to this one. Accord~
ing to the American Cancer Society
(ACS), "There are no scientifically
valid studies that show a correlation
between wearing bras of any type and
the occurrence of breast cancer. Two
anthropologists made this association
in a book called Dressed to Kill. Their
study was not conducted according to
standard principles of epidemiological
research and did n ot take into consider~
ation other variables, including known
risk factors for breast cancer. There is
no ... credible research to validate this
claim in any way."

INTERNET MYTH

#2

Using antiperspirants
causes breast cancer.

~fj:

This urgent warning claims that the
body expels toxins through perspiration
and that blocking perspiration causes
the body to deposit those toxins in
the lymph nodes, where they lead
to mutations and cancer. The ACS
disagrees: "Lymph nodes clear some
toxins from the body, but they are
not released through sweating.
The American Cancer Society is
not aware of any evidence that
shows substances in deodorants
or antiperspirants are toxic or
cause DNA damage that could
lead to cancer. Such products are
rigorously tested before they can
be marketed."

Web Sites You Can Trust

INTERNET MYTH

#3

z,;Jfj:

Microwaving food in plastic
containers releases cancercausing dioxin into the food.

Other versions of this rumor blame a
chemical called di(2~ethylhexyl)adipate
(DEHA) rather than dioxin. According
to the ACS, "The U.S. Food and Drug
Administration (FDA) says DEHA may
leach into foods wrapped in plastics ... .
But the levels are very low . .. well below
levels showing no toxic effect in animal
studies. As for dioxin, the FDA says it
'has seen no evidence that plastic
containers or films contain dioxins and
knows of no reason why they would."'

INTERNET MYTH

#4

~fj·
1

Exposing the lungs to air
during surgery for lung
cancer causes tumors to spread.

Researchers studying patients in three
U.S. cities found this belief to be fairly
widespread. In a study published in
the Annals of Internal Medicine, re~
searchers reported that 38% of all
patients surveyed believed the rumor
to be true. Among African~American
patients, the belief is even more preva~
lent: 61 % believed the rumor to be true.
The researchers could find no direct
scientific evidence that tumors spread
because of contact with air. On the
other h and, there is evidence of lower

efore ,ncorpora ting the1cJ:te-gthe-a-Jth-tnfoTmatiorrchairr~maihml"\-- ------+--ra-tes-of-ec1.r-ly---s-1:age-luflg--ea-Ree-r---stt-FgeF-V-- +your lifestyle or forwarding it to others, check out reliable Web sites.
and survival among African Americans.
This rumor could be one of the reasons
Here are some reliable sources of health information:
for the lower rates of early~stage surgery. •
• The American Cancer Society: http://www.cancer.org
• The National Cancer Institute: http://cancer.gov
For more information, contact
• The University of Texas M. D. Anderson Cancer Center:
your physician or contact the
http://www.mdanderson.org
M . D. Anderson Information Line:
• The Centers for Disease Control and Prevention: http://www.cdc.gov
• The National Institutes of Health: http://www.nih.gov
(f) (800) 392-1611, Option 3,
• The U.S. Food and Drug Administration: http://www.fda.gov
within the United States, or
Here are two sites that investigate hoaxes, rumors, and urban
legends on the Internet:
• Urban Legends and Folklore: http://urbanlegends.about.com
• Urban Legends Reference Pages: http://www.snopes.com •

(f)

(713) 792-3245 in Houston
and outside the United States.
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